Bo Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Bo Wang has a total of 108 co-authors. Here are the top co-authors by number of shared publications:
- Karen MacDonell
Center for Translational Behavioral Research, Florida State University, Tallahassee, FL, United States
7 shared publications - Sylvie Naar
Center for Translational Behavioral Research, Florida State University, Tallahassee, FL, United States
7 shared publications Lesley Cottrell
Department of Pediatrics, West Virginia University, Morgantown, USA
6 shared publicationsLynette Deveaux
Ministry of Health, Nassau, The Bahamas
6 shared publicationsXiaoming Li
University of South Carolina, Columbia, SC, USA
6 shared publicationsBonita Stanton
Hackensack Meridian School of Medicine, Nutley, USA
5 shared publications
Latest Publications
- Open Access
- 29 July 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e103611
Healthy Choices Intervention to Address Stigma, Alcohol Use, and Self-Management in Spanish-Speaking Young People With HIV: Protocol for a Pilot Randomized Controlled Implementation Study
Background: Young people with HIV experience disproportionately poor outcomes across the HIV care continuum, high levels of stigma, and elevated alcohol and other substance use. Healthy Choices is a 4-session intervention that integrates motivational interviewing with brief cognitive-behavioral strategies and has demonstrated a positive impact on HIV stigma, alcohol use, depression, and viral load in prior trials among young people with HIV. Interventions such as Healthy Choices have the potential to improve the HIV care continuum in Caribbean settings. However, no interventions have been adapted in Spanish and pilot-tested to concurrently address stigma, mental health, alcohol use, and viral burden among young people with HIV in the Dominican Republic. Objective: This study aims to adapt Healthy Choices for Spanish-speaking young people with HIV in the Dominican Republic and pilot-test the adapted intervention with implementation strategies to assess feasibility, acceptability, and a directional signal of its potential impact. Methods: Guided by the exploration, preparation, implementation, and sustainment framework and the health stigma and discrimination framework, this 36-month study has 3 specific aims. In aim 1, we will conduct focus groups with community representatives and in-depth interviews with young people with HIV to identify barriers, adaptation needs, and implementation strategies. In aim 2, we will use assessment, decision, adaptation, production, topical experts, integration, training, and testing and co-design workshops with community partners and a youth advisory board to contextually translate and adapt Healthy Choices for the Dominican Republic in Spanish, and we will train peer navigators. In aim 3, we will conduct a pilot randomized controlled trial with 45 young people with HIV using a 2:1 allocation to the adapted Healthy Choices intervention (n=30, 67%) or a time-attention control condition (n=15, 33%). Primary outcomes are feasibility and acceptability. Secondary and exploratory outcomes include antiretroviral adherence, viral load, alcohol and other substance use, social support, positive affect, coping, depression, and HIV-related stigma, which will be assessed from baseline to follow-up. Results: The study period is from March 1, 2026, to February 28, 2029. At the time of manuscript preparation, formative partnership development and key-informant consultation had been completed. The study is positioned to proceed through qualitative exploration, intervention adaptation, peer navigator training, and pilot testing across the 36-month project period. Results from the pilot trial are expected after completion of follow-up assessments. Conclusions: This protocol describes an implementation science–guided approach to adapting and testing a promising intervention for young people with HIV in a high-priority global setting with translational potential for Spanish-speaking populations in the United States. If the intervention is feasible and acceptable, the study will yield preliminary data for a future full-scale hybrid type 1 effectiveness-implementation trial. Trial Registration: ClinicalTrials.gov NCT07638618; https://tinyurl.com/5fsdn4fj International Registered Report Identifier (IRRID): PRR1-10.2196/103611
- 29 July 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e103611
Open AccessHealthy Choices Intervention to Address Stigma, Alcohol Use, and Self-Management in Spanish-Speaking Young People With HIV: Protocol for a Pilot Randomized Controlled Implementation Study
Background: Young people with HIV experience disproportionately poor outcomes across the HIV care continuum, high levels of stigma, and elevated alcohol and other substance use. Healthy Choices is a 4-session intervention that integrates motivational interviewing with brief cognitive-behavioral strategies and has demonstrated a positive impact on HIV stigma, alcohol use, depression, and viral load in prior trials among young people with HIV. Interventions such as Healthy Choices have the potential to improve the HIV care continuum in Caribbean settings. However, no interventions have been adapted in Spanish and pilot-tested to concurrently address stigma, mental health, alcohol use, and viral burden among young people with HIV in the Dominican Republic. Objective: This study aims to adapt Healthy Choices for Spanish-speaking young people with HIV in the Dominican Republic and pilot-test the adapted intervention with implementation strategies to assess feasibility, acceptability, and a directional signal of its potential impact. Methods: Guided by the exploration, preparation, implementation, and sustainment framework and the health stigma and discrimination framework, this 36-month study has 3 specific aims. In aim 1, we will conduct focus groups with community representatives and in-depth interviews with young people with HIV to identify barriers, adaptation needs, and implementation strategies. In aim 2, we will use assessment, decision, adaptation, production, topical experts, integration, training, and testing and co-design workshops with community partners and a youth advisory board to contextually translate and adapt Healthy Choices for the Dominican Republic in Spanish, and we will train peer navigators. In aim 3, we will conduct a pilot randomized controlled trial with 45 young people with HIV using a 2:1 allocation to the adapted Healthy Choices intervention (n=30, 67%) or a time-attention control condition (n=15, 33%). Primary outcomes are feasibility and acceptability. Secondary and exploratory outcomes include antiretroviral adherence, viral load, alcohol and other substance use, social support, positive affect, coping, depression, and HIV-related stigma, which will be assessed from baseline to follow-up. Results: The study period is from March 1, 2026, to February 28, 2029. At the time of manuscript preparation, formative partnership development and key-informant consultation had been completed. The study is positioned to proceed through qualitative exploration, intervention adaptation, peer navigator training, and pilot testing across the 36-month project period. Results from the pilot trial are expected after completion of follow-up assessments. Conclusions: This protocol describes an implementation science–guided approach to adapting and testing a promising intervention for young people with HIV in a high-priority global setting with translational potential for Spanish-speaking populations in the United States. If the intervention is feasible and acceptable, the study will yield preliminary data for a future full-scale hybrid type 1 effectiveness-implementation trial. Trial Registration: ClinicalTrials.gov NCT07638618; https://tinyurl.com/5fsdn4fj International Registered Report Identifier (IRRID): PRR1-10.2196/103611
- Open Access
- 17 July 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e99714
Adapting mHealth Interventions to Improve Self-Management of HIV and Reduce Substance Use Among Emerging Adults in Zambia: Protocol for a Randomized Controlled Trial
Background: Sub-Saharan Africa remains the region most affected by the HIV epidemic, with Zambia experiencing a substantial burden of disease. Young people with HIV are disproportionately impacted. Emerging adulthood (ages 18-24 years) is characterized by increasing independence, risk-taking behaviors, identity exploration, and changing social supports, all of which may impact HIV self-management, including medication adherence and retention in care. Substance use may further undermine HIV outcomes. Innovative interventions targeting HIV self-management and substance use reduction among Zambian young people are urgently needed. Objective: This study aims to develop and pilot a multicomponent mobile health (mHealth) intervention to improve HIV self-management and reduce substance use among young people in Zambia. We will adapt the 4-session in-person Healthy Choices intervention for mobile delivery (mobile Healthy Choices [mHC]) to increase access and delivery. We will also develop motivational text messaging (MTM) to enhance intervention impact. Both components will be delivered using the Computerized Intervention Authoring System. Using the multiphase optimization strategy (MOST) framework, we will assess preliminary efficacy and identify the most effective components. Methods: The study includes 3 phases. Phase 1 will involve conducting focus groups with Zambian young people with HIV to explore barriers and facilitators of HIV self-management and substance use to inform intervention adaptation. Phase 2 will involve adaptation and beta testing of mHC and MTM for functionality and feasibility using a community advisory board. Phase 3 will consist of a pilot trial using the MOST framework to evaluate feasibility, acceptability, and preliminary efficacy of intervention components. A total of 100 young people with HIV will be randomized to one of four experimental conditions: (1) standard antiretroviral therapy (ART) counseling (SAC), (2) mHC+SAC, (3) MTM+SAC, and (4) mHC+MTM+SAC. Primary outcomes will include feasibility, acceptability, ART adherence, viral suppression, and substance use. Feasibility and acceptability will be assessed through paradata of use patterns and the System Usability Scale. Participants will complete assessments at baseline and at 3- and 6-month follow-up visits. Biomarkers of ART adherence and/or sexually transmitted infections will also be collected. Results: Recruitment for this study began in May 2024 for phase 1. Focus group discussions were completed with 48 young people with HIV in July 2024. Phase 3, the pilot feasibility trial, began in June 2025. Upon project completion, we will have developed an innovative mHealth intervention to support HIV self-management and reduce substance use among Zambian young people with HIV. Conclusions: This study addresses a critical problem—suboptimal ART adherence, substance use, and challenges with HIV self-management—among young people with HIV in Zambia. We are developing 2 technology-based, theory-driven intervention components aimed at improving HIV self-management and substance use outcomes. If successful, this study will pave the way for scale-up of mHealth interventions to improve HIV care outcomes among young people with HIV in Zambia and other low-resource settings. Trial Registration: ClinicalTrials.gov NCT06415357; https://clinicaltrials.gov/study/NCT06415357 International Registered Report Identifier (IRRID): DERR1-10.2196/99714
- 17 July 2026
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 15, e99714
Open AccessAdapting mHealth Interventions to Improve Self-Management of HIV and Reduce Substance Use Among Emerging Adults in Zambia: Protocol for a Randomized Controlled Trial
Background: Sub-Saharan Africa remains the region most affected by the HIV epidemic, with Zambia experiencing a substantial burden of disease. Young people with HIV are disproportionately impacted. Emerging adulthood (ages 18-24 years) is characterized by increasing independence, risk-taking behaviors, identity exploration, and changing social supports, all of which may impact HIV self-management, including medication adherence and retention in care. Substance use may further undermine HIV outcomes. Innovative interventions targeting HIV self-management and substance use reduction among Zambian young people are urgently needed. Objective: This study aims to develop and pilot a multicomponent mobile health (mHealth) intervention to improve HIV self-management and reduce substance use among young people in Zambia. We will adapt the 4-session in-person Healthy Choices intervention for mobile delivery (mobile Healthy Choices [mHC]) to increase access and delivery. We will also develop motivational text messaging (MTM) to enhance intervention impact. Both components will be delivered using the Computerized Intervention Authoring System. Using the multiphase optimization strategy (MOST) framework, we will assess preliminary efficacy and identify the most effective components. Methods: The study includes 3 phases. Phase 1 will involve conducting focus groups with Zambian young people with HIV to explore barriers and facilitators of HIV self-management and substance use to inform intervention adaptation. Phase 2 will involve adaptation and beta testing of mHC and MTM for functionality and feasibility using a community advisory board. Phase 3 will consist of a pilot trial using the MOST framework to evaluate feasibility, acceptability, and preliminary efficacy of intervention components. A total of 100 young people with HIV will be randomized to one of four experimental conditions: (1) standard antiretroviral therapy (ART) counseling (SAC), (2) mHC+SAC, (3) MTM+SAC, and (4) mHC+MTM+SAC. Primary outcomes will include feasibility, acceptability, ART adherence, viral suppression, and substance use. Feasibility and acceptability will be assessed through paradata of use patterns and the System Usability Scale. Participants will complete assessments at baseline and at 3- and 6-month follow-up visits. Biomarkers of ART adherence and/or sexually transmitted infections will also be collected. Results: Recruitment for this study began in May 2024 for phase 1. Focus group discussions were completed with 48 young people with HIV in July 2024. Phase 3, the pilot feasibility trial, began in June 2025. Upon project completion, we will have developed an innovative mHealth intervention to support HIV self-management and reduce substance use among Zambian young people with HIV. Conclusions: This study addresses a critical problem—suboptimal ART adherence, substance use, and challenges with HIV self-management—among young people with HIV in Zambia. We are developing 2 technology-based, theory-driven intervention components aimed at improving HIV self-management and substance use outcomes. If successful, this study will pave the way for scale-up of mHealth interventions to improve HIV care outcomes among young people with HIV in Zambia and other low-resource settings. Trial Registration: ClinicalTrials.gov NCT06415357; https://clinicaltrials.gov/study/NCT06415357 International Registered Report Identifier (IRRID): DERR1-10.2196/99714
- Open Access
- 4 June 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Healthy Choices Intervention to Address Stigma, Alcohol Use, and Self-Management in Spanish-Speaking Young People With HIV: Protocol for a Pilot Randomized Controlled Implementation Study (Preprint)
BACKGROUND Young people with HIV experience disproportionately poor outcomes across the HIV care continuum, high levels of stigma, and elevated alcohol and other substance use. Healthy Choices is a 4-session intervention that integrates motivational interviewing with brief cognitive-behavioral strategies and has demonstrated a positive impact on HIV stigma, alcohol use, depression, and viral load in prior trials among young people with HIV. Interventions such as Healthy Choices have the potential to improve the HIV care continuum in Caribbean settings. However, no interventions have been adapted in Spanish and pilot-tested to concurrently address stigma, mental health, alcohol use, and viral burden among young people with HIV in the Dominican Republic. OBJECTIVE This study aims to adapt Healthy Choices for Spanish-speaking young people with HIV in the Dominican Republic and pilot-test the adapted intervention with implementation strategies to assess feasibility, acceptability, and a directional signal of its potential impact. METHODS Guided by the exploration, preparation, implementation, and sustainment framework and the health stigma and discrimination framework, this 36-month study has 3 specific aims. In aim 1, we will conduct focus groups with community representatives and in-depth interviews with young people with HIV to identify barriers, adaptation needs, and implementation strategies. In aim 2, we will use assessment, decision, adaptation, production, topical experts, integration, training, and testing and co-design workshops with community partners and a youth advisory board to contextually translate and adapt Healthy Choices for the Dominican Republic in Spanish, and we will train peer navigators. In aim 3, we will conduct a pilot randomized controlled trial with 45 young people with HIV using a 2:1 allocation to the adapted Healthy Choices intervention (n=30, 67%) or a time-attention control condition (n=15, 33%). Primary outcomes are feasibility and acceptability. Secondary and exploratory outcomes include antiretroviral adherence, viral load, alcohol and other substance use, social support, positive affect, coping, depression, and HIV-related stigma, which will be assessed from baseline to follow-up. RESULTS The study period is from March 1, 2026, to February 28, 2029. At the time of manuscript preparation, formative partnership development and key-informant consultation had been completed. The study is positioned to proceed through qualitative exploration, intervention adaptation, peer navigator training, and pilot testing across the 36-month project period. Results from the pilot trial are expected after completion of follow-up assessments. CONCLUSIONS This protocol describes an implementation science–guided approach to adapting and testing a promising intervention for young people with HIV in a high-priority global setting with translational potential for Spanish-speaking populations in the United States. If the intervention is feasible and acceptable, the study will yield preliminary data for a future full-scale hybrid type 1 effectiveness-implementation trial. CLINICALTRIAL ClinicalTrials.gov NCT07638618; https://tinyurl.com/5fsdn4fj INTERNATIONAL REGISTERED REPORT PRR1-10.2196/103611
- 4 June 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessHealthy Choices Intervention to Address Stigma, Alcohol Use, and Self-Management in Spanish-Speaking Young People With HIV: Protocol for a Pilot Randomized Controlled Implementation Study (Preprint)
BACKGROUND Young people with HIV experience disproportionately poor outcomes across the HIV care continuum, high levels of stigma, and elevated alcohol and other substance use. Healthy Choices is a 4-session intervention that integrates motivational interviewing with brief cognitive-behavioral strategies and has demonstrated a positive impact on HIV stigma, alcohol use, depression, and viral load in prior trials among young people with HIV. Interventions such as Healthy Choices have the potential to improve the HIV care continuum in Caribbean settings. However, no interventions have been adapted in Spanish and pilot-tested to concurrently address stigma, mental health, alcohol use, and viral burden among young people with HIV in the Dominican Republic. OBJECTIVE This study aims to adapt Healthy Choices for Spanish-speaking young people with HIV in the Dominican Republic and pilot-test the adapted intervention with implementation strategies to assess feasibility, acceptability, and a directional signal of its potential impact. METHODS Guided by the exploration, preparation, implementation, and sustainment framework and the health stigma and discrimination framework, this 36-month study has 3 specific aims. In aim 1, we will conduct focus groups with community representatives and in-depth interviews with young people with HIV to identify barriers, adaptation needs, and implementation strategies. In aim 2, we will use assessment, decision, adaptation, production, topical experts, integration, training, and testing and co-design workshops with community partners and a youth advisory board to contextually translate and adapt Healthy Choices for the Dominican Republic in Spanish, and we will train peer navigators. In aim 3, we will conduct a pilot randomized controlled trial with 45 young people with HIV using a 2:1 allocation to the adapted Healthy Choices intervention (n=30, 67%) or a time-attention control condition (n=15, 33%). Primary outcomes are feasibility and acceptability. Secondary and exploratory outcomes include antiretroviral adherence, viral load, alcohol and other substance use, social support, positive affect, coping, depression, and HIV-related stigma, which will be assessed from baseline to follow-up. RESULTS The study period is from March 1, 2026, to February 28, 2029. At the time of manuscript preparation, formative partnership development and key-informant consultation had been completed. The study is positioned to proceed through qualitative exploration, intervention adaptation, peer navigator training, and pilot testing across the 36-month project period. Results from the pilot trial are expected after completion of follow-up assessments. CONCLUSIONS This protocol describes an implementation science–guided approach to adapting and testing a promising intervention for young people with HIV in a high-priority global setting with translational potential for Spanish-speaking populations in the United States. If the intervention is feasible and acceptable, the study will yield preliminary data for a future full-scale hybrid type 1 effectiveness-implementation trial. CLINICALTRIAL ClinicalTrials.gov NCT07638618; https://tinyurl.com/5fsdn4fj INTERNATIONAL REGISTERED REPORT PRR1-10.2196/103611
- Open Access
- 17 March 2026
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 10 (1) , e79667
Feasibility and Engagement of a Peer-Driven Mobile Intervention for Adolescent E-Cigarette Cessation: Cluster Randomized Pilot Study
Background: E-cigarette use remains prevalent among US adolescents, with many reporting daily use and high nicotine dependence. Few evidence-based mobile health interventions focus specifically on adolescents. Objective: This study aimed to evaluate the feasibility, engagement, and preliminary efficacy of vaper-to-vaper (V2V)—a multicomponent, peer-driven texting intervention supporting adolescent e-cigarette cessation. Methods: A cluster randomized pilot study was conducted in 5 Massachusetts high schools, with schools randomized to either the V2V texting intervention (n=3) or a control group (n=2) that received a link to the National Cancer Institute’s Smokefree.gov Quit Vaping website. The V2V intervention included four components: (1) peer-written messages provided motivation, tips, and strategies to support adolescents in quitting vaping, sent daily in the first 30 days; (2) peer videos featuring adolescents sharing their experiences with e-cigarettes and motivations to quit, sent regularly as links aligned with related peer message topics; (3) peer coaches—university students aged younger than 22 years who had successfully quit vaping—trained to provide support, encouragement and answers to participants’ questions through the texting platform; and (4) a fictional, gamified mystery story integrated into the texting platform to promote engagement. Each gamified message included a short story segment and a question, with the next segment unlocked after a response or automatically after 3 days. The intervention was mainly delivered over 30 days, but adolescents could message the peer coach over the 3 months. Eligible participants (grades 9‐12, current e-cigarette users) were followed for 3 months. We assessed the feasibility of recruitment and retention (target: 80 participants, ≥85% retention), engagement with intervention components, and participant satisfaction. The secondary outcomes included improvements from baseline in confidence to quit, self-efficacy to resist vaping in specific high-risk situations, and fewer days vaped. E-cigarette cessation was biochemically verified using the Abbott iScreen cotinine test. Results: Seventy-one adolescents enrolled (intervention: 39/71, 55% ; control: 32/71, 45%), with a 96% follow-up rate at 3 months. Among intervention participants who responded to engagement items (N=37), high engagement—defined as self-reported use always, usually, or about half the time—was highest for peer messaging (n=29, 78%), followed by gamification (n=18, 49%), peer coaching (n=18, 49%), and peer video (n=13, 35%). The intervention group showed nonsignificant improvements in confidence to quit (n=17, 46%, vs n=9, 24%, moved from not at all, somewhat, or moderately confident to very or extremely confident) and in the number of days vaped in the past 30 days (−3.6 vs −2.9), while self-efficacy scores (adapted smoking self-efficacy scale range 12‐60) were slightly lower compared to the control group (mean −0.21, SD 1.14, vs mean 0.06, SD 1.39). Cotinine-validated 7-day point prevalence abstinence was similar between groups (intervention: 21.6% vs control: 22.6%). Conclusions: The V2V intervention demonstrated feasibility and acceptability, with strong engagement and high satisfaction. Although differences between groups were not statistically significant, findings suggest that peer-driven mobile interventions are a promising approach to support adolescent e-cigarette cessation.
- 17 March 2026
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 10 (1) , e79667
Open AccessFeasibility and Engagement of a Peer-Driven Mobile Intervention for Adolescent E-Cigarette Cessation: Cluster Randomized Pilot Study
Background: E-cigarette use remains prevalent among US adolescents, with many reporting daily use and high nicotine dependence. Few evidence-based mobile health interventions focus specifically on adolescents. Objective: This study aimed to evaluate the feasibility, engagement, and preliminary efficacy of vaper-to-vaper (V2V)—a multicomponent, peer-driven texting intervention supporting adolescent e-cigarette cessation. Methods: A cluster randomized pilot study was conducted in 5 Massachusetts high schools, with schools randomized to either the V2V texting intervention (n=3) or a control group (n=2) that received a link to the National Cancer Institute’s Smokefree.gov Quit Vaping website. The V2V intervention included four components: (1) peer-written messages provided motivation, tips, and strategies to support adolescents in quitting vaping, sent daily in the first 30 days; (2) peer videos featuring adolescents sharing their experiences with e-cigarettes and motivations to quit, sent regularly as links aligned with related peer message topics; (3) peer coaches—university students aged younger than 22 years who had successfully quit vaping—trained to provide support, encouragement and answers to participants’ questions through the texting platform; and (4) a fictional, gamified mystery story integrated into the texting platform to promote engagement. Each gamified message included a short story segment and a question, with the next segment unlocked after a response or automatically after 3 days. The intervention was mainly delivered over 30 days, but adolescents could message the peer coach over the 3 months. Eligible participants (grades 9‐12, current e-cigarette users) were followed for 3 months. We assessed the feasibility of recruitment and retention (target: 80 participants, ≥85% retention), engagement with intervention components, and participant satisfaction. The secondary outcomes included improvements from baseline in confidence to quit, self-efficacy to resist vaping in specific high-risk situations, and fewer days vaped. E-cigarette cessation was biochemically verified using the Abbott iScreen cotinine test. Results: Seventy-one adolescents enrolled (intervention: 39/71, 55% ; control: 32/71, 45%), with a 96% follow-up rate at 3 months. Among intervention participants who responded to engagement items (N=37), high engagement—defined as self-reported use always, usually, or about half the time—was highest for peer messaging (n=29, 78%), followed by gamification (n=18, 49%), peer coaching (n=18, 49%), and peer video (n=13, 35%). The intervention group showed nonsignificant improvements in confidence to quit (n=17, 46%, vs n=9, 24%, moved from not at all, somewhat, or moderately confident to very or extremely confident) and in the number of days vaped in the past 30 days (−3.6 vs −2.9), while self-efficacy scores (adapted smoking self-efficacy scale range 12‐60) were slightly lower compared to the control group (mean −0.21, SD 1.14, vs mean 0.06, SD 1.39). Cotinine-validated 7-day point prevalence abstinence was similar between groups (intervention: 21.6% vs control: 22.6%). Conclusions: The V2V intervention demonstrated feasibility and acceptability, with strong engagement and high satisfaction. Although differences between groups were not statistically significant, findings suggest that peer-driven mobile interventions are a promising approach to support adolescent e-cigarette cessation.
- Open Access
- 18 January 2026
- Published by Umea University Library in Journal of Community Systems for Health
- Vol. 3 (1)
Stigmas intersecting with antiretroviral adherence in young key populations living with HIV in Zambia
Introduction: Limited research has been conducted on the experiences of ART adherence among young HIV-positive men who have sex with men (MSM) and transgender women (TGW) in Zambia. This study aimed to address this evidence gap through elucidating the manifestations of stigmas intersecting with antiretroviral adherence in young key populations living with HIV in Zambia. Methods: This study used a mixed-methods design. In-depth interviews collected qualitative data, and a questionnaire collected quantitative data. We used thematic analysis for qualitative data. Qualitative data were descriptively analysed using Stata. ART adherence was defined as ever missing an ART dose (yes/no). Frequencies and percentages were generated for ART adherence by socio- demographic characteristics and stigma indicators. Results: We recruited 56 participants from three sites: Lusaka, Chipata and Solwezi districts. Participants’ mean age was 23 years. Half of the participants reported ever missing an ART dose, with equal proportions among MSM (50%) and TGW (50%). Missed doses were more frequent among participants who experienced HIV related stigma (59.4%) compared with those who did not (37.5%). Missed doses were more prevalent among those living with family (88.9%) compared to those not living with family. Stigma related to sexual orientation or gender identity (SOGI) showed mixed patterns, with no consistent differences in missed doses. Variations in adherence were observed across age, education, employment, living arrangements and care settings, however, there were no clear patterns that had emerged due to the small sample. The emergent themes were sexual orientation and gender identity–based stigma, negotiating self-identity amid uncertainty, stigma experiences in the family and ART adherence, sexual orientation, HIV ART adherence and disclosure challenges, as well as restarting ART. Conclusion: The study provides evidence of how stigmas intersect with antiretroviral therapy (ART) among young key populations. Meanwhile, most of the stigma that affected adherence to ART was related to HIV. Supporting adherence to ART among adolescents and young people, including sexual minority groups, may require tailored approaches that address their lived experiences.
- 18 January 2026
- Published by Umea University Library in Journal of Community Systems for Health
- Vol. 3 (1)
Open AccessStigmas intersecting with antiretroviral adherence in young key populations living with HIV in Zambia
Introduction: Limited research has been conducted on the experiences of ART adherence among young HIV-positive men who have sex with men (MSM) and transgender women (TGW) in Zambia. This study aimed to address this evidence gap through elucidating the manifestations of stigmas intersecting with antiretroviral adherence in young key populations living with HIV in Zambia. Methods: This study used a mixed-methods design. In-depth interviews collected qualitative data, and a questionnaire collected quantitative data. We used thematic analysis for qualitative data. Qualitative data were descriptively analysed using Stata. ART adherence was defined as ever missing an ART dose (yes/no). Frequencies and percentages were generated for ART adherence by socio- demographic characteristics and stigma indicators. Results: We recruited 56 participants from three sites: Lusaka, Chipata and Solwezi districts. Participants’ mean age was 23 years. Half of the participants reported ever missing an ART dose, with equal proportions among MSM (50%) and TGW (50%). Missed doses were more frequent among participants who experienced HIV related stigma (59.4%) compared with those who did not (37.5%). Missed doses were more prevalent among those living with family (88.9%) compared to those not living with family. Stigma related to sexual orientation or gender identity (SOGI) showed mixed patterns, with no consistent differences in missed doses. Variations in adherence were observed across age, education, employment, living arrangements and care settings, however, there were no clear patterns that had emerged due to the small sample. The emergent themes were sexual orientation and gender identity–based stigma, negotiating self-identity amid uncertainty, stigma experiences in the family and ART adherence, sexual orientation, HIV ART adherence and disclosure challenges, as well as restarting ART. Conclusion: The study provides evidence of how stigmas intersect with antiretroviral therapy (ART) among young key populations. Meanwhile, most of the stigma that affected adherence to ART was related to HIV. Supporting adherence to ART among adolescents and young people, including sexual minority groups, may require tailored approaches that address their lived experiences.
- 7 January 2026
- Published by Taylor & Francis in AIDS Care
- p. 1-13
Relationship between substance use and socio-behavioral drivers of poor ART adherence among young people with HIV in Zambia
Despite improved access to antiretroviral therapy (ART) in Zambia, adherence among young people with HIV (YPHIV) remains suboptimal, compromising treatment effectiveness. YPHIV face unique developmental and socio-behavioral challenges including HIV-related stigma, depression and substance use, which further undermine consistent ART adherence. Alcohol and drug use impair cognitive and emotional functioning, increasing the likelihood of disrupted medication routines. This study applied the Hierarchical Model of Medication Adherence (HMMA) to examine how individual, social and structural factors influence ART adherence among YPHIV in Zambia. A qualitative descriptive design was employed using six focus group discussions (FGDs) with 48 purposively selected participants aged 18-24 years, all reporting <80% adherence and recent substance use. Data were audio-recorded, transcribed verbatim and thematically analyzed. HIV-related stigma, mental health distress and negative healthcare experiences were key drivers of substance use. Substance use impaired adherence by causing forgetfulness and other factors. Depression and emotional exhaustion also emerged as major contributors to substance use and poor adherence. The study offers novel, context-specific insights into the multilevel drivers of poor adherence among Zambian youth aged 18-24. Findings highlight the need for youth-centred interventions that address stigma, mental health and substance use to improve ART adherence and health outcomes.
- 7 January 2026
- Published by Taylor & Francis in AIDS Care
- p. 1-13
Relationship between substance use and socio-behavioral drivers of poor ART adherence among young people with HIV in Zambia
Despite improved access to antiretroviral therapy (ART) in Zambia, adherence among young people with HIV (YPHIV) remains suboptimal, compromising treatment effectiveness. YPHIV face unique developmental and socio-behavioral challenges including HIV-related stigma, depression and substance use, which further undermine consistent ART adherence. Alcohol and drug use impair cognitive and emotional functioning, increasing the likelihood of disrupted medication routines. This study applied the Hierarchical Model of Medication Adherence (HMMA) to examine how individual, social and structural factors influence ART adherence among YPHIV in Zambia. A qualitative descriptive design was employed using six focus group discussions (FGDs) with 48 purposively selected participants aged 18-24 years, all reporting <80% adherence and recent substance use. Data were audio-recorded, transcribed verbatim and thematically analyzed. HIV-related stigma, mental health distress and negative healthcare experiences were key drivers of substance use. Substance use impaired adherence by causing forgetfulness and other factors. Depression and emotional exhaustion also emerged as major contributors to substance use and poor adherence. The study offers novel, context-specific insights into the multilevel drivers of poor adherence among Zambian youth aged 18-24. Findings highlight the need for youth-centred interventions that address stigma, mental health and substance use to improve ART adherence and health outcomes.
- Open Access
Subgroup analysis in multi level hierarchical cluster randomized trials
Cluster or group randomized trials (CRTs) are increasingly used for both behavioral and system-level interventions, where entire clusters are randomly assigned to a study condition or intervention. Apart from the assigned cluster-level analysis, investigating whether an intervention has a differential effect for specific subgroups remains an important issue, though it is often considered an afterthought in pivotal clinical trials. Determining such subgroup effects in a CRT is a challenging task due to its inherent nested cluster structure. Motivated by a real-life HIV prevention CRT, we consider a three-level cross-sectional CRT, where randomization is carried out at the highest level and subgroups may exist at different levels of the hierarchy. We employ a linear mixed-effects model to estimate the subgroup-specific effects through their maximum likelihood estimators (MLEs). Consequently, we develop a consistent test for the significance of the differential intervention effect between two subgroups at different levels of the hierarchy, which is the key methodological contribution of this work. We also derive explicit formulae for sample size determination to detect a differential intervention effect between two subgroups, aiming to achieve a given statistical power in the case of a planned confirmatory subgroup analysis. The application of our methodology is illustrated through extensive simulation studies using synthetic data, as well as with real-world data from an HIV prevention CRT in The Bahamas.
Open AccessSubgroup analysis in multi level hierarchical cluster randomized trials
Cluster or group randomized trials (CRTs) are increasingly used for both behavioral and system-level interventions, where entire clusters are randomly assigned to a study condition or intervention. Apart from the assigned cluster-level analysis, investigating whether an intervention has a differential effect for specific subgroups remains an important issue, though it is often considered an afterthought in pivotal clinical trials. Determining such subgroup effects in a CRT is a challenging task due to its inherent nested cluster structure. Motivated by a real-life HIV prevention CRT, we consider a three-level cross-sectional CRT, where randomization is carried out at the highest level and subgroups may exist at different levels of the hierarchy. We employ a linear mixed-effects model to estimate the subgroup-specific effects through their maximum likelihood estimators (MLEs). Consequently, we develop a consistent test for the significance of the differential intervention effect between two subgroups at different levels of the hierarchy, which is the key methodological contribution of this work. We also derive explicit formulae for sample size determination to detect a differential intervention effect between two subgroups, aiming to achieve a given statistical power in the case of a planned confirmatory subgroup analysis. The application of our methodology is illustrated through extensive simulation studies using synthetic data, as well as with real-world data from an HIV prevention CRT in The Bahamas.
- 15 January 2024
- Published by CSIRO Publishing in Sexual Health
- Vol. 21 (1)
Lived experiences with pre-exposure prophylaxis uptake and adherence among transgender women in Thailand: a qualitative study
Background: Transgender women (TGW) are disproportionately affected by HIV, and HIV prevalence among TGW in Thailand has been increasing. Although oral daily pre-exposure prophylaxis (PrEP) is effective for HIV prevention, PrEP uptake and persistence among TGW have been low. This study aimed to provide a deeper understanding of TGW’s experiences with PrEP uptake and adherence, and to identify major barriers to PrEP use to inform intervention adaptation. Methods: We interviewed 20 young TGW (six non-PrEP users, eight adherent, six non-adherent) and 10 health care providers from two HIV clinics in Bangkok, Thailand, in 2022. We focused on understanding challenges to PrEP use in this population using an interview guide based on a theoretical model of behaviour change and thematic content analysis. Results: Thematic analysis identified major barriers to and facilitators of PrEP uptake and adherence. Barriers to PrEP initiation included low self-perceived HIV risk, concern about potential side-effects, patient burdens such as frequent HIV testing for prescription refills and social stigma against PrEP. Barriers to adherence included side-effects, inconvenient access to health services (especially during COVID-19 lockdowns), forgetfulness resulting from busy schedules and low self-perceived HIV risk. TGW also reported health care providers’ stigma against PrEP users deterred them from seeking further PrEP services. TGW identified major facilitators of PrEP initiation, including awareness about the benefits of PrEP, concern about risks of HIV and supportive social networks of PrEP users. As to PrEP regimens, most TGW participants reported a clear preference for long-lasting, injectable PrEP over daily oral PrEP. TGW and health care providers largely agreed on barriers and facilitators of PrEP use, but they differed in perceptions of HIV risk. Conclusions: The results highlighted challenges and opportunities to improve the delivery of PrEP, as well as other sexually transmissable infection and mental health services, especially among TGW. Thus, there is an urgent need for developing effective intervention programs that could raise PrEP awareness and knowledge, reduce PrEP stigma, and improve PrEP delivery systems among TGW in Thailand.
- 15 January 2024
- Published by CSIRO Publishing in Sexual Health
- Vol. 21 (1)
Lived experiences with pre-exposure prophylaxis uptake and adherence among transgender women in Thailand: a qualitative study
Background: Transgender women (TGW) are disproportionately affected by HIV, and HIV prevalence among TGW in Thailand has been increasing. Although oral daily pre-exposure prophylaxis (PrEP) is effective for HIV prevention, PrEP uptake and persistence among TGW have been low. This study aimed to provide a deeper understanding of TGW’s experiences with PrEP uptake and adherence, and to identify major barriers to PrEP use to inform intervention adaptation. Methods: We interviewed 20 young TGW (six non-PrEP users, eight adherent, six non-adherent) and 10 health care providers from two HIV clinics in Bangkok, Thailand, in 2022. We focused on understanding challenges to PrEP use in this population using an interview guide based on a theoretical model of behaviour change and thematic content analysis. Results: Thematic analysis identified major barriers to and facilitators of PrEP uptake and adherence. Barriers to PrEP initiation included low self-perceived HIV risk, concern about potential side-effects, patient burdens such as frequent HIV testing for prescription refills and social stigma against PrEP. Barriers to adherence included side-effects, inconvenient access to health services (especially during COVID-19 lockdowns), forgetfulness resulting from busy schedules and low self-perceived HIV risk. TGW also reported health care providers’ stigma against PrEP users deterred them from seeking further PrEP services. TGW identified major facilitators of PrEP initiation, including awareness about the benefits of PrEP, concern about risks of HIV and supportive social networks of PrEP users. As to PrEP regimens, most TGW participants reported a clear preference for long-lasting, injectable PrEP over daily oral PrEP. TGW and health care providers largely agreed on barriers and facilitators of PrEP use, but they differed in perceptions of HIV risk. Conclusions: The results highlighted challenges and opportunities to improve the delivery of PrEP, as well as other sexually transmissable infection and mental health services, especially among TGW. Thus, there is an urgent need for developing effective intervention programs that could raise PrEP awareness and knowledge, reduce PrEP stigma, and improve PrEP delivery systems among TGW in Thailand.
- Open Access
- 4 September 2023
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 12, e46435
Adapting Effective mHealth Interventions to Improve Uptake and Adherence to HIV Pre-Exposure Prophylaxis Among Thai Young Men Who Have Sex With Men: Protocol for a Randomized Controlled Trial
Background: Young men who have sex with men (YMSM) are the fastest-growing HIV-positive population worldwide. Thailand has the highest adult HIV seroprevalence in Asia; over 25% of men having sex with men in Bangkok are HIV positive. Pre-exposure prophylaxis (PrEP) is an efficacious HIV prevention strategy recommended for all at-risk individuals. PrEP is highly effective when taken as prescribed, but PrEP utilization rate has been low, and adherence is often inadequate. Objective: We propose to develop and pilot a multicomponent, technology-based intervention to promote motivation to begin PrEP (“uptake”) and sustained adherence to PrEP among HIV-negative Thai YMSM. We will adapt an existing 2-session technology-delivered, motivational interviewing–based intervention to focus on PrEP use in YMSM in Thailand. The resulting intervention is called the Motivational Enhancement System for PrEP Uptake and Adherence (MES-PrEP). We will also develop motivational text messaging (MTM) to send two-way motivational messages to promote PrEP use. Methods: The proposed study includes 3 phases. Phase 1 includes in-depth interviews with HIV-negative Thai YMSM and providers to explore barriers and facilitators of PrEP initiation and adherence, aiming to inform intervention content. Phase 2 consists of adapting and beta-testing MES-PrEP and MTM for functionality and feasibility using a youth advisory board of Thai YMSM. In Phase 3, we will conduct a pilot randomized controlled trial to evaluate the feasibility, acceptability, and preliminary efficacy of MES-PrEP and MTM to increase PrEP uptake and adherence among Thai YMSM. A total of 60 HIV-negative Thai YMSM who have not started PrEP and 60 YMSM who are on PrEP but not adherent to it will be randomized 2:1 to receive MES-PrEP and MTM (n=40) or standard PrEP counseling (n=20). The feasibility and acceptability of the intervention will be assessed through usage patterns and the System Usability Scale. The preliminary impact will be assessed by evaluating the proportion of PrEP initiation and level of adherence to PrEP. Participants will complete the assessments at baseline and at 1-, 3-, and 6-month postintervention. Biomarkers of adherence to PrEP and biomarkers of HIV and sexually transmitted infections will be collected. Results: Recruitment for this study began in January 2022 for phase 1. Qualitative interviews were completed with 30 YMSM and 5 clinical providers in May 2022. Phase 3, the pilot feasibility and acceptability trial, began in July 2023. Upon project completion, we shall have developed a highly innovative mobile health intervention to support YMSM using PrEP, which will be ready for testing in a larger efficacy trial. Conclusions: This study addresses a critical problem (ie, high HIV incidence and low PrEP use) among Thai YMSM. We are developing 2 potentially synergistic technology-based, theory-driven interventions aimed at maximizing PrEP use. The proposed project has the potential to make significant contributions to advancing HIV prevention research and implementation science. Trial Registration: ClinicalTrials.gov NCT05243030; https://clinicaltrials.gov/ct2/show/NCT05243030 International Registered Report Identifier (IRRID): DERR1-10.2196/46435
- 4 September 2023
- Published by JMIR Publications Inc. in JMIR Research Protocols
- Vol. 12, e46435
Open AccessAdapting Effective mHealth Interventions to Improve Uptake and Adherence to HIV Pre-Exposure Prophylaxis Among Thai Young Men Who Have Sex With Men: Protocol for a Randomized Controlled Trial
Background: Young men who have sex with men (YMSM) are the fastest-growing HIV-positive population worldwide. Thailand has the highest adult HIV seroprevalence in Asia; over 25% of men having sex with men in Bangkok are HIV positive. Pre-exposure prophylaxis (PrEP) is an efficacious HIV prevention strategy recommended for all at-risk individuals. PrEP is highly effective when taken as prescribed, but PrEP utilization rate has been low, and adherence is often inadequate. Objective: We propose to develop and pilot a multicomponent, technology-based intervention to promote motivation to begin PrEP (“uptake”) and sustained adherence to PrEP among HIV-negative Thai YMSM. We will adapt an existing 2-session technology-delivered, motivational interviewing–based intervention to focus on PrEP use in YMSM in Thailand. The resulting intervention is called the Motivational Enhancement System for PrEP Uptake and Adherence (MES-PrEP). We will also develop motivational text messaging (MTM) to send two-way motivational messages to promote PrEP use. Methods: The proposed study includes 3 phases. Phase 1 includes in-depth interviews with HIV-negative Thai YMSM and providers to explore barriers and facilitators of PrEP initiation and adherence, aiming to inform intervention content. Phase 2 consists of adapting and beta-testing MES-PrEP and MTM for functionality and feasibility using a youth advisory board of Thai YMSM. In Phase 3, we will conduct a pilot randomized controlled trial to evaluate the feasibility, acceptability, and preliminary efficacy of MES-PrEP and MTM to increase PrEP uptake and adherence among Thai YMSM. A total of 60 HIV-negative Thai YMSM who have not started PrEP and 60 YMSM who are on PrEP but not adherent to it will be randomized 2:1 to receive MES-PrEP and MTM (n=40) or standard PrEP counseling (n=20). The feasibility and acceptability of the intervention will be assessed through usage patterns and the System Usability Scale. The preliminary impact will be assessed by evaluating the proportion of PrEP initiation and level of adherence to PrEP. Participants will complete the assessments at baseline and at 1-, 3-, and 6-month postintervention. Biomarkers of adherence to PrEP and biomarkers of HIV and sexually transmitted infections will be collected. Results: Recruitment for this study began in January 2022 for phase 1. Qualitative interviews were completed with 30 YMSM and 5 clinical providers in May 2022. Phase 3, the pilot feasibility and acceptability trial, began in July 2023. Upon project completion, we shall have developed a highly innovative mobile health intervention to support YMSM using PrEP, which will be ready for testing in a larger efficacy trial. Conclusions: This study addresses a critical problem (ie, high HIV incidence and low PrEP use) among Thai YMSM. We are developing 2 potentially synergistic technology-based, theory-driven interventions aimed at maximizing PrEP use. The proposed project has the potential to make significant contributions to advancing HIV prevention research and implementation science. Trial Registration: ClinicalTrials.gov NCT05243030; https://clinicaltrials.gov/ct2/show/NCT05243030 International Registered Report Identifier (IRRID): DERR1-10.2196/46435
- 2 September 2023
- Published by SAGE Publications in Health Education & Behavior
- Vol. 50 (6) , 770-782
Effects of Teacher Training and Continued Support on the Delivery of an Evidence-Based HIV Prevention Program: Findings From a National Implementation Study in the Bahamas
Background: Few studies have investigated the effects of teacher training and continued support on teachers’ delivery of evidence-based HIV prevention programs. We examined these factors in a national implementation study of an evidence-based HIV risk reduction intervention for adolescents in the sixth grade in the Bahamas. Methods: Data were collected from 126 grade 6 teachers and 3,118 students in 58 government elementary schools in the Bahamas in 2019–2021. This is a Hybrid Type III implementation study guided by the Exploration, Preparation, Implementation, Sustainment (EPIS) model. Teachers attended 2-day training workshops. Trained school coordinators and peer mentors provided biweekly monitoring and mentorship. We used mixed-effects models to assess the effects of teacher training and continued support on implementation fidelity. Results: Teachers who received training in-person or both in-person and online taught the most core activities (27.0 and 27.2 of 35), versus only online training (21.9) and no training (14.9) ( F = 15.27, p < .001). Teachers with an “excellent” or “very good” school coordinator taught more core activities than those with a “satisfactory” coordinator or no coordinator (29.2 vs. 27.8 vs. 19.3 vs. 14.8, F = 29.20, p < .001). Teachers with a “very good” mentor taught more core activities and sessions than those with a “satisfactory” mentor or no mentor (30.4 vs. 25.0 vs. 23.1; F = 7.20; p < .01). Teacher training, implementation monitoring, peer mentoring, teachers’ self-efficacy, and school-level support were associated with implementation fidelity, which in turn was associated with improved student outcomes (HIV/AIDS knowledge, preventive reproductive health skills, self-efficacy, and intention to use protection). Conclusion: Teachers receiving in-person training and those having higher-rated school coordinator and mentor support taught a larger number of HIV prevention core activities. Effective teacher training, implementation monitoring, and peer mentoring are critical for improving implementation fidelity and student outcomes.
- 2 September 2023
- Published by SAGE Publications in Health Education & Behavior
- Vol. 50 (6) , 770-782
Effects of Teacher Training and Continued Support on the Delivery of an Evidence-Based HIV Prevention Program: Findings From a National Implementation Study in the Bahamas
Background: Few studies have investigated the effects of teacher training and continued support on teachers’ delivery of evidence-based HIV prevention programs. We examined these factors in a national implementation study of an evidence-based HIV risk reduction intervention for adolescents in the sixth grade in the Bahamas. Methods: Data were collected from 126 grade 6 teachers and 3,118 students in 58 government elementary schools in the Bahamas in 2019–2021. This is a Hybrid Type III implementation study guided by the Exploration, Preparation, Implementation, Sustainment (EPIS) model. Teachers attended 2-day training workshops. Trained school coordinators and peer mentors provided biweekly monitoring and mentorship. We used mixed-effects models to assess the effects of teacher training and continued support on implementation fidelity. Results: Teachers who received training in-person or both in-person and online taught the most core activities (27.0 and 27.2 of 35), versus only online training (21.9) and no training (14.9) ( F = 15.27, p < .001). Teachers with an “excellent” or “very good” school coordinator taught more core activities than those with a “satisfactory” coordinator or no coordinator (29.2 vs. 27.8 vs. 19.3 vs. 14.8, F = 29.20, p < .001). Teachers with a “very good” mentor taught more core activities and sessions than those with a “satisfactory” mentor or no mentor (30.4 vs. 25.0 vs. 23.1; F = 7.20; p < .01). Teacher training, implementation monitoring, peer mentoring, teachers’ self-efficacy, and school-level support were associated with implementation fidelity, which in turn was associated with improved student outcomes (HIV/AIDS knowledge, preventive reproductive health skills, self-efficacy, and intention to use protection). Conclusion: Teachers receiving in-person training and those having higher-rated school coordinator and mentor support taught a larger number of HIV prevention core activities. Effective teacher training, implementation monitoring, and peer mentoring are critical for improving implementation fidelity and student outcomes.